ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis

Journal of Innate Immunity

Volumn 1, Issue 5, 2009, Pages 494-506

  McGillivray, Shauna M ^a   Ebrahimi, Celia M ^a   Fisher, Nathan ^f   Sabet, Mojgan ^b   Zhang, Dawn X ^a   Chen, Yahua ^g   Haste, Nina M ^c   Aroian, Raffi V ^d   Gallo, Richard L ^b   Guiney, Donald G ^b   Friedlander, Arthur M ^f   Koehler, Theresa M ^g   Nizet, Victor ^a,c,e,h  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e RADY CHILDREN'S HOSPITAL   (United States)

^f UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimicrobial peptides; Bacillus anthracis; Bacterial infection; Cathelicidins; Hemolysis; Innate immunity; Protease; Transposon mutagenesis; Virulence factor

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AGAR; ALPHA DEFENSIN; CASEIN; CATHELICIDIN; ENDOPEPTIDASE CLPX; LYSOZYME; POLYPEPTIDE ANTIBIOTIC AGENT; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACILLUS ANTHRACIS; BLOOD; CONTROLLED STUDY; EXPERIMENTAL MODEL; GENE DELETION; GUINEA PIG; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MALE; MOUSE; MUTAGENESIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; SURVIVAL; TRANSPOSON; VIRULENCE; WILD TYPE;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTHRAX; ANTIMICROBIAL CATIONIC PEPTIDES; BACILLUS ANTHRACIS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; ENDOPEPTIDASE CLP; GUINEA PIGS; HEMOLYSIS; HUMANS; IMMUNITY, INNATE; MICE; MUTAGENESIS; PHENOTYPE; VIRULENCE; VIRULENCE FACTORS;

EID: 77953395311     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000225955     Document Type: Article

References (40)

1. Dixon TC, Meselson M, Guillemin J, Hanna PC: Anthrax. N Engl J Med 1999;341:815-826.
2. Banks DJ, Ward SC, Bradley KA: New insights into the functions of anthrax toxin. Expert Rev Mol Med 2006;8:1-18.
3. Ezzell JW, Welkos SL: The capsule of Bacillus anthracis , a review. J Appl Microbiol 1999;87:250.
4. Read TD, Peterson SN, Tourasse N, Baillie LW, Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen JA, Gill SR, Holtzapple EK, Okstad OA, Helgason E, Rilstone J, Wu M, Kolonay JF, Beanan MJ, Dodson RJ, Brinkac LM, Gwinn M, DeBoy RT, Madpu R, Daugherty SC, Durkin AS, Haft DH, Nelson WC, Peterson JD, Pop M, Khouri HM, Radune D, Benton JL, Mahamoud Y, Jiang L, Hance IR, Weidman JF, Berry KJ, Plaut RD, Wolf AM, Watkins KL, Nierman WC, Hazen A, Cline R, Redmond C, Thwaite JE, White O, Salzberg SL, Thomason B, Friedlander AM, Koehler TM, Hanna PC, Kolsto AB, Fraser CM: The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 2003;423:81-86.
5. Frees D, Savijoki K, Varmanen P, Ingmer H: Clp ATPases and ClpP proteolytic complexes regulate vital biological processes in low GC, Gram-positive bacteria. Mol Microbiol 2007;63:1285-1295.
6. Kessel M, Maurizi MR, Kim B, Kocsis E, Trus BL, Singh SK, Steven AC: Homology in structural organization between E. coli ClpAP protease and the eukaryotic 26 S proteasome. J Mol Biol 1995;250:587-594.
7. Woo KM, Chung WJ, Ha DB, Goldberg AL, Chung CH: Protease Ti from Escherichia coli requires ATP hydrolysis for protein breakdown but not for hydrolysis of small peptides. J Biol Chem 1989;264:2088-2091.
8. Wawrzynow A, Wojtkowiak D, Marszalek J, Banecki B, Jonsen M, Graves B, Georgopoulos C, Zylicz M: The ClpX heat-shock protein of Escherichia coli , the ATP-dependent substrate specificity component of the ClpPClpX protease, is a novel molecular chaperone. EMBO J 1995;14:1867-1877.
9. Flynn JM, Neher SB, Kim YI, Sauer RT, Baker TA: Proteomic discovery of cellular substrates of the ClpXP protease reveals five classes of ClpX-recognition signals. Mol Cell 2003;11:671-683.
10. Liu J, Cosby WM, Zuber P: Role of Lon and ClpX in the post-translational regulation of a sigma subunit of RNA polymerase required for cellular differentiation in Bacillus subtilis . Mol Microbiol 1999;33:415-428. (Pubitemid 29322527)
11. Chen Y, Tenover FC, Koehler TM: Beta-lactamase gene expression in a penicillin-resistant Bacillus anthracis strain. Antimicrob Agents Chemother 2004;48:4873-4877.
12. Lampe DJ, Akerley BJ, Rubin EJ, Mekalanos JJ, Robertson HM: Hyperactive transposase mutants of the Himar1 mariner transposon. Proc Natl Acad Sci USA 1999;96:11428-11433.
13. Dunn AK, Handelsman J: A vector for promoter trapping in Bacillus cereus . Gene 1999;226:297-305.
14. Koehler TM, Dai Z, Kaufman-Yarbray M: Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans -acting element activate transcription from one of two promoters. J Bacteriol 1994;176:586-595.
15. Shannon JG, Ross CL, Koehler TM, Rest RF: Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin. Infect Immun 2003;71:3183-3189.
16. Green BD, Battisti L, Koehler TM, Thorne CB, Ivins BE: Demonstration of a capsule plasmid in Bacillus anthracis . Infect Immun 1985;49:291-297.
17. Nicholson WL, Setow P: Sporulation, germination and outgrowth; in Harwood CR, Cutting SM (eds): Molecular biological methods for Bacillus. Chichester, John Wiley & Sons, 1990, pp 391-450.
18. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001;414:454-457. (Pubitemid 34173727)
19. Klichko VI, Miller J, Wu A, Popov SG, Alibek K: Anaerobic induction of Bacillus anthracis hemolytic activity. Biochem Biophys Res Commun 2003;303:855-862.
20. Lampe DJ, Grant TE, Robertson HM: Factors affecting transposition of the Himar1 mariner transposon in vitro. Genetics 1998;149:179-187. (Pubitemid 28246796)
21. Tam C, Glass EM, Anderson DM, Missiakas D: Transposon mutagenesis of Bacillus anthracis strain Sterne using Bursa aurealis . Plasmid 2006;56:74-77.
22. Wilson AC, Perego M, Hoch JA: New transposon delivery plasmids for insertional mutagenesis in Bacillus anthracis . J Microbiol Methods 2007;71:332-335.
23. Hadjifrangiskou M, Chen Y, Koehler TM: The alternative sigma factor SigmaH is required for toxin gene expression by Bacillus anthracis . J Bacteriol 2007;189:1874-1883.
24. Peschel A: How do bacteria resist human antimicrobial peptides? Trends Microbiol 2002;10:179-186.
25. Thwaite JE, Hibbs S, Titball RW, Atkins TP: Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrob Agents Chemother 2006;50:2316-2322.
26. Lisanby MW, Swiecki MK, Dizon BL, Pflughoeft KJ, Koehler TM, Kearney JF: Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol 2008;181:4989-5000.
27. Klotman ME, Chang TL: Defensins in innate antiviral immunity. Nat Rev Immunol 2006;6:447-456.
28. Kurosaka K, Chen Q, Yarovinsky F, Oppenheim JJ, Yang D: Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol 2005;174:6257-6265. (Pubitemid 40663818)
29. Panyutich AV, Panyutich EA, Krapivin VA, Baturevich EA, Ganz T: Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med 1993;122:202-207.
30. Popov SG, Popova TG, Hopkins S, Weinstein RS, MacAfee R, Fryxell KJ, Chandhoke V, Bailey C, Alibek K: Effective antiproteaseantibiotic treatment of experimental anthrax. BMC Infect Dis 2005; 5: 25. (Pubitemid 41363801)
31. Gat O, Mendelson I, Chitlaru T, Ariel N, Altboum Z, Levy H, Weiss S, Grosfeld H, Cohen S, Shafferman A: The solute-binding component of a putative Mn(II) abc transporter (MntA) is a novel Bacillus anthracis virulence determinant. Mol Microbiol 2005;58:533-551.
32. Bergman NH, Anderson EC, Swenson EE, Niemeyer MM, Miyoshi AD, Hanna PC: Transcriptional profiling of the Bacillus anthracis life cycle in vitro and an implied model for regulation of spore formation. J Bacteriol 2006;188:6092-6100.
33. Fisher N, Shetron-Rama L, Herring-Palmer A, Heffernan B, Bergman N, Hanna P: The dlt ABCD operon of Bacillus anthracis Sterne is required for virulence and resistance to peptide, enzymatic, and cellular mediators of innate immunity. J Bacteriol 2006;188:1301-1309.
34. Frees D, Qazi SN, Hill PJ, Ingmer H: Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence. Mol Microbiol 2003;48:1565-1578.
35. Frees D, Sorensen K, Ingmer H: Global virulence regulation in Staphylococcus aureus : Pinpointing the roles of ClpP and ClpX in the sar/agr regulatory network. Infect Immun 2005;73:8100-8108.
36. Huang LC, Reins RY, Gallo RL, McDermott AM: Cathelicidin-deficient (CnlP-/-) mice show increased susceptibility to Pseudomonas aeruginos a keratitis. Invest Ophthalmol Vis Sci 2007;48:4498-4508.
37. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF: Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 2005;174:4901-4907. (Pubitemid 40504574)
38. Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, Ehren I, Hokfelt T, Gudmundsson GH, Gallo RL, Agerberth B, Brauner A: The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 2006;12:636-641. (Pubitemid 43865231)
39. Bergman P, Johansson L, Wan H, Jones A, Gallo RL, Gudmundsson GH, Hokfelt T, Jonsson AB, Agerberth B: Induction of the antimicrobial peptide cramp in the bloodbrain barrier and meninges after meningococcal infection. Infect Immun 2006;74:6982-6991. (Pubitemid 44913173)
40. Brotz-Oesterhelt H, Beyer D, Kroll HP, Endermann R, Ladel C, Schroeder W, Hinzen B, Raddatz S, Paulsen H, Henninger K, Bandow JE, Sahl HG, Labischinski H: Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med 2005;11:1082-1087. (Pubitemid 41486830)